Portola Pharmaceuticals and its executives, who are working to develop and commercialize novel therapeutics in the fields of thrombosis and other hematologic diseases, have been recognized for their contributions with the following awards:
10th Annual Pantheon Award:
Portola Received the 2013 DiNA Outstanding Company Award
Each year, BayBio recognizes achievement and honors excellence in the life sciences industry in Northern California, as it brings together Northern California’s life sciences industry leaders. The Pantheon Awards Ceremony is a celebration of the contributions and achievements of the Bay Area, a moment to pause and reflect on the industry’s legacy over three decades.
Portola Named Among Top 10 Biotech IPOs of 2013
Each year, FierceBiotech selects the top 10 biotech companies that completed an Initial Public Offering (IPO). The selection, made by Editor-in-Chief John Carroll is based on a mix of the IPO price compared with the range plus the amount raised and the subsequent increase in share price.
San Francisco Business Times:
Mardi Dier, Portola CFO, Selected as One of Most Influential Women in Bay Area Business
Annually, the San Francisco Business Times selects female executives to be honored as the Most Influential Women in Bay Area Business. The list recognizes outstanding women professionals who make a difference in their companies, industries and communities.